Tag: cell therapy technologies market research

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

#Cell Therapy Technologies Market Size And Revenue Forecast Through 2030

The cell therapy technologies market experienced significant expansion recently, with projections indicating a rise from $5.67 billion in 2025 to $6.52 billion in 2026, reflecting a compound annual growth rate of 15.0%. During the preceding period, this expansion was fueled by a surge in clinical investigations for cell-based treatments, a greater acceptance of stem cell therapies, the broadening of research cell repositories, the accessibility of sophisticated bioprocessing tools, and advancements in translational medicine initiatives.

The cell therapy technologies market is poised for substantial expansion, projected to reach $11.35 billion by 2030, demonstrating a robust compound annual growth rate of 14.8%. This upward trajectory in the upcoming years is fueled by several key factors: the escalating commercial availability of cell-based treatments, increased financial backing for regenerative medicine research, the proliferation of localized cell therapy systems, a heightened need for automated production processes, and a stronger emphasis from regulatory bodies on maintaining consistent manufacturing standards. Within this forecast period, significant market currents include the growing embrace of enclosed cell processing systems, greater utilization of automated cell cultivation equipment, an expanding requirement for manufacturing processes that can be scaled up effectively for cell therapies, advancements in tools for monitoring processes and ensuring quality, and a greater concentration on uniform methods for handling cells.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4122&type=smp

#Cell Therapy Technologies Market Growth Factors: Which Forces Are Supporting Market Expansion?

The escalating incidence of cancer is anticipated to be a primary catalyst for the expansion of the cell therapy technologies market throughout the projected period, as cell therapy itself leverages living cells as therapeutic agents for disease intervention, specifically harnessing the body’s immune system to identify and eliminate aberrant cells when applied to oncological treatments; for example, data from the American Cancer Society, a US non-profit organization dedicated to cancer advocacy, revealed a rise from 1,958,310 cases in 2023 to 2,001,140 in January 2024, signifying a 2.19% increase, thus, this upward trend in cancer diagnoses is poised to fuel the future growth of the cell therapy technologies sector.

Cell Therapy Technologies Market Segment Outlook: Which Categories Are Expanding The Fastest?

The cell therapy technologies market covered in this report is segmented –

1) By Product: Consumables, Equipment, Systems And Software

2) By Cell Type: T-Cells, Stem Cells, Other Cell Types

3) By Process: Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control

4) By End User: Life Science Companies, Research Institutes And Cell Banks

Subsegments:

1) By Consumables: Cell Culture Media, Bioreactors And Cell Culture Vessels, Cell Separation And Processing Kits, Cryopreservation Bags And Vials

2) By Equipment: Cell Counters, Centrifuges, Cell Sorting Equipment, Incubators

3) By Systems And Software: Closed-System Cell Processing Systems, Automated Cell Culture Systems, Point-Of-Care Cell Therapy Systems, Laboratory Information Management Systems (LIMS), Data Management Software For Cell Therapies, Process Optimization And Tracking Software

Cell Therapy Technologies Market Industry Trends: What Changes Are Reshaping Demand?

Leading entities within the cell therapy sector are dedicated to pioneering technological progress, including the implementation of automated manufacturing systems aimed at enhancing the capacity, consistency, and productivity of cell-based therapeutic creation. These automated cell therapy solutions incorporate sophisticated robotics, real-time process oversight, and contained production environments to optimize output while upholding the integrity of cellular material and adhering to regulatory standards. As an illustration, the year 2025 witnessed Limula, a United States firm specializing in cell therapies, introduce a novel automated platform engineered to expedite the manufacturing of cell therapies, minimize human involvement, and elevate the uniformity and dependability of therapeutic cell products. This platform’s introduction signifies a crucial advancement towards achieving commercial-scale cell therapy manufacturing, thereby facilitating a more rapid transition from experimental stages to practical medical use.

Cell Therapy Technologies Market Key Companies And Competitive Benchmarking

Major companies operating in the cell therapy technologies market are Lonza Group AG, Thermo Fisher Scientific Inc, Merck KGaA, Terumo Corporation, Danaher Corporation, Fujifilm Holdings Corporation, Sartorius AG, Becton Dickinson and Company, Avantor Inc., Cellular Biomedicine Group, CORESTEM, Astellas Pharma Inc, Anterogen Co. Ltd, Arce Therapeutics, CARsgen Therapeutics, Co.Don AG, Neogene Therapeutics, GammaDelta Therapeutics Limited, SOTIO, Genestack, Novartis AG, Celgene Corporation, Gilead Sciences, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Amgen, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Next BioSciences, CryoSave, BioHeart, Stem Cell Technologies

Access The Complete Cell Therapy Technologies Market Report:

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Cell Therapy Technologies Market Regional Distribution: Which Areas Drive Market Expansion?

North Americawas the largest region in the cell therapy technologies market in 2025. Asia-Pacificis predicted to record the fastest growth over the forecast period. The regions covered in the cell therapy technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

#Cell Therapy Technologies Market Size And Revenue Forecast Through 2030

The cell therapy technologies market experienced significant expansion recently, with projections indicating a rise from $5.67 billion in 2025 to $6.52 billion in 2026, reflecting a compound annual growth rate of 15.0%. During the preceding period, this expansion was fueled by a surge in clinical investigations for cell-based treatments, a greater acceptance of stem cell therapies, the broadening of research cell repositories, the accessibility of sophisticated bioprocessing tools, and advancements in translational medicine initiatives.

The cell therapy technologies market is poised for substantial expansion, projected to reach $11.35 billion by 2030, demonstrating a robust compound annual growth rate of 14.8%. This upward trajectory in the upcoming years is fueled by several key factors: the escalating commercial availability of cell-based treatments, increased financial backing for regenerative medicine research, the proliferation of localized cell therapy systems, a heightened need for automated production processes, and a stronger emphasis from regulatory bodies on maintaining consistent manufacturing standards. Within this forecast period, significant market currents include the growing embrace of enclosed cell processing systems, greater utilization of automated cell cultivation equipment, an expanding requirement for manufacturing processes that can be scaled up effectively for cell therapies, advancements in tools for monitoring processes and ensuring quality, and a greater concentration on uniform methods for handling cells.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4122&type=smp

#Cell Therapy Technologies Market Growth Factors: Which Forces Are Supporting Market Expansion?

The escalating incidence of cancer is anticipated to be a primary catalyst for the expansion of the cell therapy technologies market throughout the projected period, as cell therapy itself leverages living cells as therapeutic agents for disease intervention, specifically harnessing the body’s immune system to identify and eliminate aberrant cells when applied to oncological treatments; for example, data from the American Cancer Society, a US non-profit organization dedicated to cancer advocacy, revealed a rise from 1,958,310 cases in 2023 to 2,001,140 in January 2024, signifying a 2.19% increase, thus, this upward trend in cancer diagnoses is poised to fuel the future growth of the cell therapy technologies sector.

Cell Therapy Technologies Market Segment Outlook: Which Categories Are Expanding The Fastest?

The cell therapy technologies market covered in this report is segmented –

1) By Product: Consumables, Equipment, Systems And Software

2) By Cell Type: T-Cells, Stem Cells, Other Cell Types

3) By Process: Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control

4) By End User: Life Science Companies, Research Institutes And Cell Banks

Subsegments:

1) By Consumables: Cell Culture Media, Bioreactors And Cell Culture Vessels, Cell Separation And Processing Kits, Cryopreservation Bags And Vials

2) By Equipment: Cell Counters, Centrifuges, Cell Sorting Equipment, Incubators

3) By Systems And Software: Closed-System Cell Processing Systems, Automated Cell Culture Systems, Point-Of-Care Cell Therapy Systems, Laboratory Information Management Systems (LIMS), Data Management Software For Cell Therapies, Process Optimization And Tracking Software

Cell Therapy Technologies Market Industry Trends: What Changes Are Reshaping Demand?

Leading entities within the cell therapy sector are dedicated to pioneering technological progress, including the implementation of automated manufacturing systems aimed at enhancing the capacity, consistency, and productivity of cell-based therapeutic creation. These automated cell therapy solutions incorporate sophisticated robotics, real-time process oversight, and contained production environments to optimize output while upholding the integrity of cellular material and adhering to regulatory standards. As an illustration, the year 2025 witnessed Limula, a United States firm specializing in cell therapies, introduce a novel automated platform engineered to expedite the manufacturing of cell therapies, minimize human involvement, and elevate the uniformity and dependability of therapeutic cell products. This platform’s introduction signifies a crucial advancement towards achieving commercial-scale cell therapy manufacturing, thereby facilitating a more rapid transition from experimental stages to practical medical use.

Cell Therapy Technologies Market Key Companies And Competitive Benchmarking

Major companies operating in the cell therapy technologies market are Lonza Group AG, Thermo Fisher Scientific Inc, Merck KGaA, Terumo Corporation, Danaher Corporation, Fujifilm Holdings Corporation, Sartorius AG, Becton Dickinson and Company, Avantor Inc., Cellular Biomedicine Group, CORESTEM, Astellas Pharma Inc, Anterogen Co. Ltd, Arce Therapeutics, CARsgen Therapeutics, Co.Don AG, Neogene Therapeutics, GammaDelta Therapeutics Limited, SOTIO, Genestack, Novartis AG, Celgene Corporation, Gilead Sciences, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Amgen, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Next BioSciences, CryoSave, BioHeart, Stem Cell Technologies

Access The Complete Cell Therapy Technologies Market Report:

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Cell Therapy Technologies Market Regional Distribution: Which Areas Drive Market Expansion?

North Americawas the largest region in the cell therapy technologies market in 2025. Asia-Pacificis predicted to record the fastest growth over the forecast period. The regions covered in the cell therapy technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

#Cell Therapy Technologies Market Size And Revenue Forecast Through 2030

The cell therapy technologies market experienced significant expansion recently, with projections indicating a rise from $5.67 billion in 2025 to $6.52 billion in 2026, reflecting a compound annual growth rate of 15.0%. During the preceding period, this expansion was fueled by a surge in clinical investigations for cell-based treatments, a greater acceptance of stem cell therapies, the broadening of research cell repositories, the accessibility of sophisticated bioprocessing tools, and advancements in translational medicine initiatives.

The cell therapy technologies market is poised for substantial expansion, projected to reach $11.35 billion by 2030, demonstrating a robust compound annual growth rate of 14.8%. This upward trajectory in the upcoming years is fueled by several key factors: the escalating commercial availability of cell-based treatments, increased financial backing for regenerative medicine research, the proliferation of localized cell therapy systems, a heightened need for automated production processes, and a stronger emphasis from regulatory bodies on maintaining consistent manufacturing standards. Within this forecast period, significant market currents include the growing embrace of enclosed cell processing systems, greater utilization of automated cell cultivation equipment, an expanding requirement for manufacturing processes that can be scaled up effectively for cell therapies, advancements in tools for monitoring processes and ensuring quality, and a greater concentration on uniform methods for handling cells.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4122&type=smp

#Cell Therapy Technologies Market Growth Factors: Which Forces Are Supporting Market Expansion?

The escalating incidence of cancer is anticipated to be a primary catalyst for the expansion of the cell therapy technologies market throughout the projected period, as cell therapy itself leverages living cells as therapeutic agents for disease intervention, specifically harnessing the body’s immune system to identify and eliminate aberrant cells when applied to oncological treatments; for example, data from the American Cancer Society, a US non-profit organization dedicated to cancer advocacy, revealed a rise from 1,958,310 cases in 2023 to 2,001,140 in January 2024, signifying a 2.19% increase, thus, this upward trend in cancer diagnoses is poised to fuel the future growth of the cell therapy technologies sector.

Cell Therapy Technologies Market Segment Outlook: Which Categories Are Expanding The Fastest?

The cell therapy technologies market covered in this report is segmented –

1) By Product: Consumables, Equipment, Systems And Software

2) By Cell Type: T-Cells, Stem Cells, Other Cell Types

3) By Process: Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control

4) By End User: Life Science Companies, Research Institutes And Cell Banks

Subsegments:

1) By Consumables: Cell Culture Media, Bioreactors And Cell Culture Vessels, Cell Separation And Processing Kits, Cryopreservation Bags And Vials

2) By Equipment: Cell Counters, Centrifuges, Cell Sorting Equipment, Incubators

3) By Systems And Software: Closed-System Cell Processing Systems, Automated Cell Culture Systems, Point-Of-Care Cell Therapy Systems, Laboratory Information Management Systems (LIMS), Data Management Software For Cell Therapies, Process Optimization And Tracking Software

Cell Therapy Technologies Market Industry Trends: What Changes Are Reshaping Demand?

Leading entities within the cell therapy sector are dedicated to pioneering technological progress, including the implementation of automated manufacturing systems aimed at enhancing the capacity, consistency, and productivity of cell-based therapeutic creation. These automated cell therapy solutions incorporate sophisticated robotics, real-time process oversight, and contained production environments to optimize output while upholding the integrity of cellular material and adhering to regulatory standards. As an illustration, the year 2025 witnessed Limula, a United States firm specializing in cell therapies, introduce a novel automated platform engineered to expedite the manufacturing of cell therapies, minimize human involvement, and elevate the uniformity and dependability of therapeutic cell products. This platform’s introduction signifies a crucial advancement towards achieving commercial-scale cell therapy manufacturing, thereby facilitating a more rapid transition from experimental stages to practical medical use.

Cell Therapy Technologies Market Key Companies And Competitive Benchmarking

Major companies operating in the cell therapy technologies market are Lonza Group AG, Thermo Fisher Scientific Inc, Merck KGaA, Terumo Corporation, Danaher Corporation, Fujifilm Holdings Corporation, Sartorius AG, Becton Dickinson and Company, Avantor Inc., Cellular Biomedicine Group, CORESTEM, Astellas Pharma Inc, Anterogen Co. Ltd, Arce Therapeutics, CARsgen Therapeutics, Co.Don AG, Neogene Therapeutics, GammaDelta Therapeutics Limited, SOTIO, Genestack, Novartis AG, Celgene Corporation, Gilead Sciences, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Amgen, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Next BioSciences, CryoSave, BioHeart, Stem Cell Technologies

Access The Complete Cell Therapy Technologies Market Report:

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Cell Therapy Technologies Market Regional Distribution: Which Areas Drive Market Expansion?

North Americawas the largest region in the cell therapy technologies market in 2025. Asia-Pacificis predicted to record the fastest growth over the forecast period. The regions covered in the cell therapy technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Rise In Market Size Of The Cell Therapy Technologies Market During The Forecast Period?

The cell transfection market has observed robust growth in recent years. The market size is anticipated to expand from $1.42 billion in 2025 to $1.55 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.2%. This historic period’s growth is primarily due to the expansion of molecular biology research, the increasing use of gene expression studies, the growth in recombinant protein production, the rising adoption of in vitro genetic manipulation, and the availability of diverse transfection methods.

The cell transfection market is anticipated to experience substantial expansion over the coming years, with its valuation projected to reach $2.17 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.9%. This projected growth during the forecast period stems from factors such as the accelerated development of gene and cell therapies, escalating investments in genetic engineering research, an increasing need for high-throughput screening assays, the broadening scope of personalized medicine research, and the expanding adoption of non-viral delivery technologies. Key trends anticipated during the same period encompass the growing uptake of high-efficiency transfection reagents, the increasing application of viral vector-based transfection, a rising requirement for scalable transfection methods, the expansion of automated transfection platforms, and a heightened emphasis on transfection reproducibility.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4122&type=smp

What Important Drivers Are Powering The Cell Therapy Technologies Market Growth?

The future growth of the cell transfection market is expected to be propelled by the rising number of infectious disease cases. Infectious diseases are illnesses resulting from germs that spread from one individual to another or through tainted sources. The inadequate state of public health infrastructure, alongside vaccine hesitancy and the dissemination of misinformation, has contributed to the spread and adaptation of pathogens. Cell transfection serves as a potent tool for infectious diseases, enabling scientists to introduce genes into cells to examine how infections affect them and to test novel treatments. For instance, in October 2024, according to the World Health Organization, a Switzerland-based international public health organization, approximately 8.2 million people were newly diagnosed with tuberculosis in 2023, an increase from about 7.5 million in 2022, identifying tuberculosis as the leading infectious disease killer. Consequently, the escalating number of infectious disease cases drives the cell transfection market.

What Key Segment Areas Are Included In The Cell Therapy Technologies Market Assessment?

The cell therapy technologies market covered in this report is segmented –

1) By Product: Consumables, Equipment, Systems And Software

2) By Cell Type: T-Cells, Stem Cells, Other Cell Types

3) By Process: Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control

4) By End User: Life Science Companies, Research Institutes And Cell Banks

Subsegments:

1) By Consumables: Cell Culture Media, Bioreactors And Cell Culture Vessels, Cell Separation And Processing Kits, Cryopreservation Bags And Vials

2) By Equipment: Cell Counters, Centrifuges, Cell Sorting Equipment, Incubators

3) By Systems And Software: Closed-System Cell Processing Systems, Automated Cell Culture Systems, Point-Of-Care Cell Therapy Systems, Laboratory Information Management Systems (LIMS), Data Management Software For Cell Therapies, Process Optimization And Tracking Software

Which Trends Are Expected To Shape The Cell Therapy Technologies Market?

Major companies operating in the cell transfection market are incorporating innovations into their transfection systems to enable exact control over gene expression. A transfection system is a method or technology designed to insert foreign nucleic acids into cells to investigate gene function, synthesize proteins, or modify gene expression. For instance, in July 2024, STEMCELL Technologies, a Canada-based biotechnology company, introduced its Cellpore transfection system. This new tool is developed to improve cell engineering research. The system utilizes sophisticated microfluidic technology to facilitate the internal cellular delivery of diverse macromolecules, thereby overcoming constraints associated with conventional transfection approaches. It has the capability to transfect up to 10 million cells per second, rendering it suitable for applications requiring high throughput. The system is compatible with various cell types, including T cells and hematopoietic stem cells, and can deliver diverse cargoes such as small molecules, Ribonucleic Acid (RNA), proteins, and antibodies.

Which Firms Are Competing In The Cell Therapy Technologies Market?

Major companies operating in the cell therapy technologies market are Lonza Group AG, Thermo Fisher Scientific Inc, Merck KGaA, Terumo Corporation, Danaher Corporation, Fujifilm Holdings Corporation, Sartorius AG, Becton Dickinson and Company, Avantor Inc., Cellular Biomedicine Group, CORESTEM, Astellas Pharma Inc, Anterogen Co. Ltd, Arce Therapeutics, CARsgen Therapeutics, Co.Don AG, Neogene Therapeutics, GammaDelta Therapeutics Limited, SOTIO, Genestack, Novartis AG, Celgene Corporation, Gilead Sciences, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Amgen, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Next BioSciences, CryoSave, BioHeart, Stem Cell Technologies

Access The Complete Cell Therapy Technologies Market Report:

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Which Region Stands As The Largest Contributor To The Cell Therapy Technologies Market?

North America was the largest region in the cell therapy technologies market in 2025. Asia-Pacific is predicted to record the fastest growth over the forecast period. The regions covered in the cell therapy technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Cell Therapy Technologies Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=4122&type=smp

Browse Through More Reports Similar to the Global Cell Therapy Technologies Market 2026, By The Business Research Company

Metal Structural Insulation Panels Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/metal-structural-insulation-panels-global-market-report

Vacuum Insulation Panel Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/vacuum-insulation-panel-global-market-report

Exterior Insulation And Finish System Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/exterior-insulation-and-finish-system-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Cell Therapy Technologies Market From 2026 To 2030?

The cell therapy technologies market has experienced rapid growth in recent years. It is projected to expand from $5.67 billion in 2025 to $6.52 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.0%. The historical growth can be attributed to an increase in clinical research involving cell-based therapies, the rising acceptance of stem cell treatments, the expansion of research cell banks, the availability of advanced bioprocessing equipment, and the development of translational medicine programs.

The cell therapy technologies market size is forecast to experience significant expansion in the upcoming years. It is projected to grow to $11.35 billion by 2030, achieving a compound annual growth rate (CAGR) of 14.8%. This anticipated growth is propelled by the increasing commercialization of cell therapies, rising investments in regenerative medicine, the expansion of point-of-care cell therapy systems, a growing demand for automated manufacturing workflows, and an increasing regulatory focus on process consistency. Prominent trends for this period include the wider adoption of closed-system cell processing platforms, an increase in the use of automated cell culture systems, a growing need for scalable cell therapy manufacturing, the expansion of process monitoring and quality control tools, and an enhanced emphasis on standardized cell handling.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

What Primary Drivers Are Shaping The Cell Therapy Technologies Market?

The rising incidence of cancer is projected to propel the expansion of the cell therapy technologies market over the forecast period. This therapeutic approach involves employing living cells as medicinal agents to combat illnesses. Specifically for cancer treatment, cell therapy leverages the inherent capacity of the immune system to identify and eliminate aberrant cells within the body. An illustrative example is seen in January 2024, where data from the American Cancer Society, a US-based nonprofit cancer advocacy organization, indicated a rise in cancer cases to 2,001,140, up from 1,958,310 in 2023, representing a 2.19% increase. Consequently, the growing volume of cancer diagnoses is anticipated to foster the development of the cell therapy technologies market moving forward.

How Is Segmentation Applied In The Cell Therapy Technologies Market Segment Analysis?

The cell therapy technologies market covered in this report is segmented –

1) By Product: Consumables, Equipment, Systems And Software

2) By Cell Type: T-Cells, Stem Cells, Other Cell Types

3) By Process: Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control

4) By End User: Life Science Companies, Research Institutes And Cell Banks

Subsegments:

1) By Consumables: Cell Culture Media, Bioreactors And Cell Culture Vessels, Cell Separation And Processing Kits, Cryopreservation Bags And Vials

2) By Equipment: Cell Counters, Centrifuges, Cell Sorting Equipment, Incubators

3) By Systems And Software: Closed-System Cell Processing Systems, Automated Cell Culture Systems, Point-Of-Care Cell Therapy Systems, Laboratory Information Management Systems (LIMS), Data Management Software For Cell Therapies, Process Optimization And Tracking Software

What Trends Are Affecting The Growth Of The Cell Therapy Technologies Market?

Leading companies within the cell therapy market are prioritizing the development of advanced technological solutions, specifically automated manufacturing platforms, to enhance the scalability, reproducibility, and efficiency in the creation of cell-based therapies. These automated cell therapy technologies integrate robotics, sophisticated process monitoring, and closed-system manufacturing to streamline production processes, all while upholding cell quality and ensuring regulatory compliance. A notable example occurred in 2025 when Limula, a US-based cell therapy company, unveiled an automated cell therapy platform designed to accelerate cell manufacturing, reduce the need for manual intervention, and improve the consistency and safety of therapeutic cell products. The introduction of this platform signifies a crucial advancement toward commercial-scale cell therapy production, enabling a quicker transition from research findings to clinical applications.

Who Are The Companies Participating In The Cell Therapy Technologies Market Environment?

Major companies operating in the cell therapy technologies market are Lonza Group AG, Thermo Fisher Scientific Inc, Merck KGaA, Terumo Corporation, Danaher Corporation, Fujifilm Holdings Corporation, Sartorius AG, Becton Dickinson and Company, Avantor Inc., Cellular Biomedicine Group, CORESTEM, Astellas Pharma Inc, Anterogen Co. Ltd, Arce Therapeutics, CARsgen Therapeutics, Co.Don AG, Neogene Therapeutics, GammaDelta Therapeutics Limited, SOTIO, Genestack, Novartis AG, Celgene Corporation, Gilead Sciences, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Amgen, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Next BioSciences, CryoSave, BioHeart, Stem Cell Technologies

Get The Full Cell Therapy Technologies Market Report:

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Which Region Accounts For The Largest Portion Of The Cell Therapy Technologies Market?

North America was the largest region in the cell therapy technologies market in 2025. Asia-Pacific is predicted to record the fastest growth over the forecast period. The regions covered in the cell therapy technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cell Therapy Technologies Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Browse Through More Reports Similar to the Global Cell Therapy Technologies Market 2026, By The Business Research Company

Stem Cells Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Cells Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Cell Therapy Human Raw Materials Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-therapy-human-raw-materials-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Cell Therapy Technologies Market By The End Of 2030?

The cell therapy technologies market size has experienced rapid growth in recent years. It is projected to expand from $5.67 billion in 2025 to $6.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.0%. This historical growth can be attributed to increasing clinical research in cell-based therapies, the rising adoption of stem cell treatments, the expansion of research cell banks, the availability of advanced bioprocessing equipment, and the growth in translational medicine programs.

The cell therapy technologies market is projected to experience substantial expansion in the coming years. This market is set to reach $11.35 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.8%. Key drivers for this growth during the forecast period include the expanding commercialization of cell therapies, a surge in investments directed towards regenerative medicine, the proliferation of point-of-care cell therapy systems, an escalating need for automated manufacturing workflows, and an intensified regulatory emphasis on process consistency. Prominent trends observed over the forecast period encompass a greater uptake of closed-system cell processing platforms, a rise in the utilization of automated cell culture systems, an increasing imperative for scalable cell therapy manufacturing, the wider availability of process monitoring and quality control instruments, and a heightened emphasis on standardized cell handling.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4122&type=smp

What Primary Drivers Are Shaping The Development Of The Cell Therapy Technologies Market?

The rising incidence of cancer is anticipated to propel the expansion of the cell therapy technologies market during the forecast period. Cell therapy utilizes living cells as therapeutic agents to treat various diseases. When applied to cancer, this therapy harnesses the immune system’s intrinsic capability to detect and eliminate abnormal cells within the body. For instance, in January 2024, the American Cancer Society, a US-based nonprofit cancer advocacy organization, reported an increase in cancer cases to 2,001,140, up from 1,958,310 in 2023, representing a growth of 2.19%. Thus, the growing number of cancer cases is expected to contribute significantly to the growth of the cell therapy technologies market going forward.

Which Segment Classifications Shape The Cell Therapy Technologies Market?

The cell therapy technologies market covered in this report is segmented –

1) By Product: Consumables, Equipment, Systems And Software

2) By Cell Type: T-Cells, Stem Cells, Other Cell Types

3) By Process: Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control

4) By End User: Life Science Companies, Research Institutes And Cell Banks

Subsegments:

1) By Consumables: Cell Culture Media, Bioreactors And Cell Culture Vessels, Cell Separation And Processing Kits, Cryopreservation Bags And Vials

2) By Equipment: Cell Counters, Centrifuges, Cell Sorting Equipment, Incubators

3) By Systems And Software: Closed-System Cell Processing Systems, Automated Cell Culture Systems, Point-Of-Care Cell Therapy Systems, Laboratory Information Management Systems (LIMS), Data Management Software For Cell Therapies, Process Optimization And Tracking Software

Which Upcoming Trends Are Expected To Influence The Cell Therapy Technologies Market?

Major companies within the cell therapy market are concentrating on developing advanced technological solutions, specifically automated manufacturing platforms, to enhance the scalability, reproducibility, and efficiency of producing cell-based therapies. These automated cell therapy technologies integrate robotics, process monitoring, and closed-system manufacturing, which serves to streamline production while upholding cell quality and ensuring regulatory adherence. For example, in 2025, Limula, a US-based cell therapy company, introduced an automated cell therapy platform specifically designed to accelerate cell manufacturing, reduce the need for manual intervention, and improve the consistency and safety of therapeutic cell products. The launch of this platform signifies a crucial advancement toward commercial-scale cell therapy production, enabling a quicker transition from research to clinical application.

Which Companies Are Expanding Their Footprint In The Cell Therapy Technologies Market?

Major companies operating in the cell therapy technologies market are Lonza Group AG, Thermo Fisher Scientific Inc, Merck KGaA, Terumo Corporation, Danaher Corporation, Fujifilm Holdings Corporation, Sartorius AG, Becton Dickinson and Company, Avantor Inc., Cellular Biomedicine Group, CORESTEM, Astellas Pharma Inc, Anterogen Co. Ltd, Arce Therapeutics, CARsgen Therapeutics, Co.Don AG, Neogene Therapeutics, GammaDelta Therapeutics Limited, SOTIO, Genestack, Novartis AG, Celgene Corporation, Gilead Sciences, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Amgen, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Next BioSciences, CryoSave, BioHeart, Stem Cell Technologies

Read the full cell therapy technologies market report here:

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

How Does The Cell Therapy Technologies Market Perform Across Major Global Regions?

North America was the largest region in the cell therapy technologies market in 2025. Asia-Pacific is predicted to record the fastest growth over the forecast period. The regions covered in the cell therapy technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cell Therapy Technologies Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=4122&type=smp

Browse Through More Reports Similar to the Global Cell Therapy Technologies Market 2026, By The Business Research Company

Metal Structural Insulation Panels Global Market Report

https://www.thebusinessresearchcompany.com/report/metal-structural-insulation-panels-global-market-report

Vacuum Insulation Panel Global Market Report

https://www.thebusinessresearchcompany.com/report/vacuum-insulation-panel-global-market-report

Exterior Insulation And Finish System Global Market Report

https://www.thebusinessresearchcompany.com/report/exterior-insulation-and-finish-system-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Cell Therapy Technologies Market By The End Of 2030?

The cell therapy technologies market size has experienced rapid growth in recent years. It is projected to expand from $5.67 billion in 2025 to $6.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.0%. This historical growth can be attributed to increasing clinical research in cell-based therapies, the rising adoption of stem cell treatments, the expansion of research cell banks, the availability of advanced bioprocessing equipment, and the growth in translational medicine programs.

The cell therapy technologies market is projected to experience substantial expansion in the coming years. This market is set to reach $11.35 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.8%. Key drivers for this growth during the forecast period include the expanding commercialization of cell therapies, a surge in investments directed towards regenerative medicine, the proliferation of point-of-care cell therapy systems, an escalating need for automated manufacturing workflows, and an intensified regulatory emphasis on process consistency. Prominent trends observed over the forecast period encompass a greater uptake of closed-system cell processing platforms, a rise in the utilization of automated cell culture systems, an increasing imperative for scalable cell therapy manufacturing, the wider availability of process monitoring and quality control instruments, and a heightened emphasis on standardized cell handling.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4122&type=smp

What Primary Drivers Are Shaping The Development Of The Cell Therapy Technologies Market?

The rising incidence of cancer is anticipated to propel the expansion of the cell therapy technologies market during the forecast period. Cell therapy utilizes living cells as therapeutic agents to treat various diseases. When applied to cancer, this therapy harnesses the immune system’s intrinsic capability to detect and eliminate abnormal cells within the body. For instance, in January 2024, the American Cancer Society, a US-based nonprofit cancer advocacy organization, reported an increase in cancer cases to 2,001,140, up from 1,958,310 in 2023, representing a growth of 2.19%. Thus, the growing number of cancer cases is expected to contribute significantly to the growth of the cell therapy technologies market going forward.

Which Segment Classifications Shape The Cell Therapy Technologies Market?

The cell therapy technologies market covered in this report is segmented –

1) By Product: Consumables, Equipment, Systems And Software

2) By Cell Type: T-Cells, Stem Cells, Other Cell Types

3) By Process: Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control

4) By End User: Life Science Companies, Research Institutes And Cell Banks

Subsegments:

1) By Consumables: Cell Culture Media, Bioreactors And Cell Culture Vessels, Cell Separation And Processing Kits, Cryopreservation Bags And Vials

2) By Equipment: Cell Counters, Centrifuges, Cell Sorting Equipment, Incubators

3) By Systems And Software: Closed-System Cell Processing Systems, Automated Cell Culture Systems, Point-Of-Care Cell Therapy Systems, Laboratory Information Management Systems (LIMS), Data Management Software For Cell Therapies, Process Optimization And Tracking Software

Which Upcoming Trends Are Expected To Influence The Cell Therapy Technologies Market?

Major companies within the cell therapy market are concentrating on developing advanced technological solutions, specifically automated manufacturing platforms, to enhance the scalability, reproducibility, and efficiency of producing cell-based therapies. These automated cell therapy technologies integrate robotics, process monitoring, and closed-system manufacturing, which serves to streamline production while upholding cell quality and ensuring regulatory adherence. For example, in 2025, Limula, a US-based cell therapy company, introduced an automated cell therapy platform specifically designed to accelerate cell manufacturing, reduce the need for manual intervention, and improve the consistency and safety of therapeutic cell products. The launch of this platform signifies a crucial advancement toward commercial-scale cell therapy production, enabling a quicker transition from research to clinical application.

Which Companies Are Expanding Their Footprint In The Cell Therapy Technologies Market?

Major companies operating in the cell therapy technologies market are Lonza Group AG, Thermo Fisher Scientific Inc, Merck KGaA, Terumo Corporation, Danaher Corporation, Fujifilm Holdings Corporation, Sartorius AG, Becton Dickinson and Company, Avantor Inc., Cellular Biomedicine Group, CORESTEM, Astellas Pharma Inc, Anterogen Co. Ltd, Arce Therapeutics, CARsgen Therapeutics, Co.Don AG, Neogene Therapeutics, GammaDelta Therapeutics Limited, SOTIO, Genestack, Novartis AG, Celgene Corporation, Gilead Sciences, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Amgen, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Next BioSciences, CryoSave, BioHeart, Stem Cell Technologies

Read the full cell therapy technologies market report here:

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

How Does The Cell Therapy Technologies Market Perform Across Major Global Regions?

North America was the largest region in the cell therapy technologies market in 2025. Asia-Pacific is predicted to record the fastest growth over the forecast period. The regions covered in the cell therapy technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cell Therapy Technologies Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=4122&type=smp

Browse Through More Reports Similar to the Global Cell Therapy Technologies Market 2026, By The Business Research Company

Metal Structural Insulation Panels Global Market Report

https://www.thebusinessresearchcompany.com/report/metal-structural-insulation-panels-global-market-report

Vacuum Insulation Panel Global Market Report

https://www.thebusinessresearchcompany.com/report/vacuum-insulation-panel-global-market-report

Exterior Insulation And Finish System Global Market Report

https://www.thebusinessresearchcompany.com/report/exterior-insulation-and-finish-system-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Cell Therapy Technologies Market By The End Of 2030?

The cell therapy technologies market size has experienced rapid growth in recent years. It is projected to expand from $5.67 billion in 2025 to $6.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.0%. This historical growth can be attributed to increasing clinical research in cell-based therapies, the rising adoption of stem cell treatments, the expansion of research cell banks, the availability of advanced bioprocessing equipment, and the growth in translational medicine programs.

The cell therapy technologies market is projected to experience substantial expansion in the coming years. This market is set to reach $11.35 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.8%. Key drivers for this growth during the forecast period include the expanding commercialization of cell therapies, a surge in investments directed towards regenerative medicine, the proliferation of point-of-care cell therapy systems, an escalating need for automated manufacturing workflows, and an intensified regulatory emphasis on process consistency. Prominent trends observed over the forecast period encompass a greater uptake of closed-system cell processing platforms, a rise in the utilization of automated cell culture systems, an increasing imperative for scalable cell therapy manufacturing, the wider availability of process monitoring and quality control instruments, and a heightened emphasis on standardized cell handling.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4122&type=smp

What Primary Drivers Are Shaping The Development Of The Cell Therapy Technologies Market?

The rising incidence of cancer is anticipated to propel the expansion of the cell therapy technologies market during the forecast period. Cell therapy utilizes living cells as therapeutic agents to treat various diseases. When applied to cancer, this therapy harnesses the immune system’s intrinsic capability to detect and eliminate abnormal cells within the body. For instance, in January 2024, the American Cancer Society, a US-based nonprofit cancer advocacy organization, reported an increase in cancer cases to 2,001,140, up from 1,958,310 in 2023, representing a growth of 2.19%. Thus, the growing number of cancer cases is expected to contribute significantly to the growth of the cell therapy technologies market going forward.

Which Segment Classifications Shape The Cell Therapy Technologies Market?

The cell therapy technologies market covered in this report is segmented –

1) By Product: Consumables, Equipment, Systems And Software

2) By Cell Type: T-Cells, Stem Cells, Other Cell Types

3) By Process: Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control

4) By End User: Life Science Companies, Research Institutes And Cell Banks

Subsegments:

1) By Consumables: Cell Culture Media, Bioreactors And Cell Culture Vessels, Cell Separation And Processing Kits, Cryopreservation Bags And Vials

2) By Equipment: Cell Counters, Centrifuges, Cell Sorting Equipment, Incubators

3) By Systems And Software: Closed-System Cell Processing Systems, Automated Cell Culture Systems, Point-Of-Care Cell Therapy Systems, Laboratory Information Management Systems (LIMS), Data Management Software For Cell Therapies, Process Optimization And Tracking Software

Which Upcoming Trends Are Expected To Influence The Cell Therapy Technologies Market?

Major companies within the cell therapy market are concentrating on developing advanced technological solutions, specifically automated manufacturing platforms, to enhance the scalability, reproducibility, and efficiency of producing cell-based therapies. These automated cell therapy technologies integrate robotics, process monitoring, and closed-system manufacturing, which serves to streamline production while upholding cell quality and ensuring regulatory adherence. For example, in 2025, Limula, a US-based cell therapy company, introduced an automated cell therapy platform specifically designed to accelerate cell manufacturing, reduce the need for manual intervention, and improve the consistency and safety of therapeutic cell products. The launch of this platform signifies a crucial advancement toward commercial-scale cell therapy production, enabling a quicker transition from research to clinical application.

Which Companies Are Expanding Their Footprint In The Cell Therapy Technologies Market?

Major companies operating in the cell therapy technologies market are Lonza Group AG, Thermo Fisher Scientific Inc, Merck KGaA, Terumo Corporation, Danaher Corporation, Fujifilm Holdings Corporation, Sartorius AG, Becton Dickinson and Company, Avantor Inc., Cellular Biomedicine Group, CORESTEM, Astellas Pharma Inc, Anterogen Co. Ltd, Arce Therapeutics, CARsgen Therapeutics, Co.Don AG, Neogene Therapeutics, GammaDelta Therapeutics Limited, SOTIO, Genestack, Novartis AG, Celgene Corporation, Gilead Sciences, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Amgen, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Next BioSciences, CryoSave, BioHeart, Stem Cell Technologies

Read the full cell therapy technologies market report here:

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

How Does The Cell Therapy Technologies Market Perform Across Major Global Regions?

North America was the largest region in the cell therapy technologies market in 2025. Asia-Pacific is predicted to record the fastest growth over the forecast period. The regions covered in the cell therapy technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cell Therapy Technologies Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=4122&type=smp

Browse Through More Reports Similar to the Global Cell Therapy Technologies Market 2026, By The Business Research Company

Metal Structural Insulation Panels Global Market Report

https://www.thebusinessresearchcompany.com/report/metal-structural-insulation-panels-global-market-report

Vacuum Insulation Panel Global Market Report

https://www.thebusinessresearchcompany.com/report/vacuum-insulation-panel-global-market-report

Exterior Insulation And Finish System Global Market Report

https://www.thebusinessresearchcompany.com/report/exterior-insulation-and-finish-system-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model